Table 3

Tumor response assessment and correlation toKRASmutational status
All patients All WT Codon 12 mutation Codon 13 mutation p-value
No. of patients% 201 128 58 15
100 63.6 28.9 7.5
ORR% 55 63 49 23 0.008
95% CI (49–61) (54–71) (37–62) (8–51) (Chi-Square)
DCR% 85 88 81 77 0.29
95% CI (80–90) (80–92) (68–89) (49–93) (Chi-Square)

All patients. Percentages based on non-missing data, p-values for WT vs Codon 12 mutations vs codon 13 mutations; WT wild type; ORR overall response rate, DCR disease control rate.

Reinacher-Schick et al.

Reinacher-Schick et al. BMC Cancer 2012 12:349   doi:10.1186/1471-2407-12-349

Open Data